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Activated properdin factor D(I~) ~ is a  23,500 mol wt euglobulin that acts on 
factor B  in the presence of either cobra venom factor  (COVE) 2 (4) or C3b  (5), 
the major cleavage product of C3,  to form the  CoVF-dependent  and  C3b-de- 
pendent [C3B  (D)] C3 convertases. These convertases are similar to the classi- 
cal convertase, C42  (7), in their ability to cleave C3  and subsequently to acti- 
vate  the  terminal  complement  sequence  C5-C9.  Furthermore,  EAC43B(l~), 
the cellular intermediate bearing the convertase, is hemolyzed by reaction with 
C3-C9  (8). The role of factor B  during the decay and regeneration of C3-B(I~) 
is analogous to  that  of  C2  in  the reactions of C4"-2 (8).  ]D has been  shown  re- 
cently to be analogous to CI: both cleave proteins that participate in the genera- 
tion and decay of their respective C3 convertases, are susceptible to inhibition 
by diisopropylphosphofluoridate (DFP),  and  are  derived from  DFP-resistant 
precursor forms, D  and C1,  which may be activated by proteolytic treatment 
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1 The  nomenclature  for  the  classical  complement components  conforms  to  that  agreed 
upon under the auspices of  the World Health Organization (1968, Bull.  W. H. O.  39:395). 
Properdin factor B is synonymous with C3 proactivator (1) and glycine-rich beta-glycoprotein 
(2); precursor factor D  (3) is denoted by D; activated factor D  (4) is represented  as ~  and 
apparently is identical to C3 proaetivator convertase (5) and GBGase  (6). The cellular in- 
termediate bearing the  C3b-dependent  C3  convertase  is represented by EAC43B(]~);  the 
parentheses are placed about D  to indicate that its presence  in the intermediate is not es- 
tablished. 
Abbreviations used in this paper: CoVF,  cobra venom factor; DFP, diisopropylphospho- 
fluoridate; GVB- EDTA, VBS containing 0.1% gelatin and 0.04 M EDTA; mS, milliSiemens; 
QAE, quaternary aminoethyl; SP, sulphopropyl; TLCK, tosyl-L-lysine ehloromethyl ketone; 
VBS, Veronal-buffered saline; Z, the average number of hemolytic sites/cell. 
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with trypsin (3, 9). Implicit in the identification of the precursor form of D  is 
the existence of a  plasma protein responsible for its physiologic activation. In 
the present study,  an activated form of properdin (10),  a  184,000 mol wt (11) 
gamma globulin, is shown to convert D  to D. 
Materials and Methods 
Hexadimethrine bromide and DFP (Aldrich Chemical Co., Inc., Milwaukee, Wise.), tosyl- 
L-lysine chloromethyl ketone (TLCK) (Cyclo  Chemical, Div. Travenol Laboratories, Inc., 
Los Angeles,  Calif.), Indubiose agarose  (Fisher Scientific  Co., Pittsburgh, Pa.), rat serum 
(Pel-Freez Biologicals,  Rodgers, Ark.), and zymosan lot. no. Y3660  (Schwarz/Mann Div., 
Becton, Dickinson and Co., Orangeburg, N.Y.) were obtained as indicated. 
The Preparation and Assay of Classical Complement Components and Properdin Factors.- 
Low ionic strength Veronai-buffered saline (VBS)  with dextrose  (DGVB++), pH  7.5,  3.75 
milliSiemens (mS),  containing 5 X  10  -4 M  Mg  ++, 1.5 X  10  --4 M  Ca  ++ and 0.1% gelatin, 
and VBS containing 0.1% gelatin and 0.04 M EDTA (GVB-EDTA) were used as dihients in 
hemolytic assays.  EAC43 were prepared as previously described (8) except that guinea pig 
C2, 200 effective molecules/cell, was used in place of human C2, and EAC423 were decayed 
at 37"C for 180 rain to remove the C2. In the assay for ~i (3),  I  X  lif  t EAC43 and 6 ng of 
factor B in 0.1 ml DGVB  ++ were incubated with the test samples in 0.1 ml DGVB++ for 30 
rain at 30°C to generate the EAC43B (~--) intermediate. 0.3 ml of rat serum diluted 1:15 in 
GVB-EDTA (C-EDTA) was added to the reaction mixture and incubation continued for 60 
rain at 37°C. The extent of hemolysis was determined and the average number of hemolytic 
sites/cell (Z) calculated. 
Guinea pig CT (12) and C2  (12) and human C3 were isolated and quantitated as previ- 
ously described (13, 14). Properdin factor D  was isolated from plasma collected  in hexadi- 
methrine and EDTA by quaternary aminoethyl (QAE) Sephadex  (Pharmacia Fine Chemicals, 
Piseataway, N. J.)  chromatography and two filtrations through Sephadex  G-75  (3).  ~  was 
prepared from a pH 6.0 euglobulin precipitate of fresh frozen citrated plasma by identical 
chromatographic procedures. The preparation of ~  exhibited a single band on alkaline disc 
gel electrophoresis  (Canalco Inc., Rockville, Md.) which corresponded to the position in a 
replicate gel from which activity was eluted. Protein concentrations  in D and ~  preparations 
were measured by the Folin assay (15) with serum albumin as the standard. Properdin fac- 
tor B, isolated and quantitated as previously described (4, 16) was homogeneous on alkaline 
disc gel electrophoresis and was devoid of C2 by hemolytic assay (17). 
Chromatography of and Immunochemical Assay for Properdin.--Anion exchange chroma- 
tography was performed with QAE Sephadex  A-50 equilibrated in 0.0035 M  PO4, 0.002 M 
EDTA, pH  8.0.  Sulphopropyl (SP)  Sephadex  C-25  was equilibrated with 0.0035  M  PO4, 
0.002 M EDTA, pH 7.5, and utilized for cation exchange chromatography. Conductance was 
measured at 0°C and expressed  as mS.  Sephadex  G-200 Superfine gel filtration was carried 
out on a  1.5 x 60 cm column by upward flow with VBS containing 0.002  M  EDTA.  The 
elution volumes were  calculated from the net weight of the fractions in pre-weighed  plastic 
tubes. The column was calibrated by the elution volumes of C4, IgG, transferrin, and albumin 
contained in a serum sample and detected by radial immunodiffusion. Acid disc gel electro- 
phoresis  of properdin was performed in 7.5% gels according to instructions supplied by the 
manufacturer (Canalco). 
Properdin was detected immunochemically in column fractions by radial immunodiffusion 
using monospecific  rabbit antihuman properdin. The antiserum, prepared by immunization 
with zymosan-eluted properdin  (18) and rendered monospecific  by adsorption with serum 
depleted of properdin (18), demonstrated the same specificity as that provided by Dr. I. H. 
Lepow  (19). The immunodittusion gels, 2 mm thick, were prepared after diluting the anti- 428  ACTIVATION OF  FACTOR  D  BY  PROPERDIN 
serum 1:275 in VBS containing 0.005 M EDTA and 1.5% agarose. Wells 3 mm in diameter 
were used for screening the QAE Sephadex column, and 2 mm in diameter for the SP Sepha- 
dex and Sephadex G-200 columns. Mter allowing diffusion of the samples for 24 h at 37°C, 
the precipitin rings were developed with 1% tannic acid in water  (20), and the  diameters 
measured with a calibrated eyepiece. In plates containing serum samples or the final purified 
preparations, wells 2 mm in diameter were used, the samples allowed to diffuse for 72 h at 
25°C, and the plates washed overnight in 0.075 M NaCI before staining with tannic acid. 
Properdin concentrations were calculated from a standard serum which had been calibrated 
against 50 normal sera whose mean properdin concentration was taken as 25 #g/ml (19). 
RESULTS 
Since neither C3b nor factor B, alone or in combination, activated D(3), the 
initial search for a factor with this capacity focused on the other known protein 
of the properdin pathway, properdin itself. In order to minimize alterations in 
native properdin, it was isolated directly from plasma, rather than by elution 
from zymosan or euglobulin precipitation. 
Conversion of Factor D to D  by Activated Properdin.--80 ml of fresh plasma 
obtained from blood drawn into plastic tubes containing hexadimethrine  (3.6 
mg/10 ml blood) and EDTA  (10 rag/10 ml blood)  (21)  were dialyzed at 4°C 
against the QAE  Sephadex starting buffer. After centrifugation,  the resulting 
supernate  was  applied  to  a  5  ×  90  cm  column  containing  QAE  Sephadex. 
Fractions  containing  properdin,  as  assessed  by  radial  immunodiffusion,  ap- 
peared in the early effluent, just before the initial protein peak.  These fractions 
were pooled and concentrated by ultrafiltration to 5 ml, dialyzed at 4°C against 
the SP Sephadex starting buffer, and applied to a 0.9 X  30 cm column contain- 
ing SP Sephadex.  Elution  with a  linear salt gradient  and assay by radial im- 
munodiffusion revealed two distinct peaks of properdin, at 6.5 mS (peak  I) and 
7.2  mS  (peak II)  (Fig.  1).  The fractions were examined also for their  ability 
to activate D. 50 #1 of 1:20 dilutions in DGVB  ++ of the column fractions were 
added to 50 ng D  in 50 #1 DGVB  ++, and the reaction mixtures were assessed 
for i5  by their  capacity to form EAC43B(D).  Fractions  were examined also 
for their inherent content of 15 activity by omission of D  from the assay. Frac- 
tions in peak I  demonstrated minimal capacity to form EAC43B(15)  and had 
no I5 activity by themselves (Fig. 1). The chromatographic fractions containing 
peak II were capable of generating l~ from its precursor and exhibited some 
activity in  the  absence of added D. The fractions containing properdin were 
assessed  also  for  prekallikrein,  plasminogen  proactivator,  and  preplasma 
thromboplastin  antecedent  (21)  and  were  found  to  be  devoid  of  activities 
associated with these proteins. Although some trailing of the ability to activate 
D  was observed, attention was focused on peak II. 
In order to analyze further the association between properdin antigen  con- 
tained in peak II with  activation of D,  the second peak was pooled, concen- 
trated to 0.75 ml, and filtered on Sephadex G-200. Fractions were screened for 
properdin  by radial  immunodiffusion,  and for the  capacity to  activate D  by 
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to  the fractions containing the  ability to  activate D  and  to  those  exhibiting 
activity in the absence of D  (Fig. 2). 
To  assess  the  relationship between  protein  content  and  the  ability of  the 
properdin obtained by Sephadex G-200 gel filtration to activate D,  analytical 
disc gel electrophoresis was performed.  Fractions containing the peak of pro- 
perdin  eluted from  Sephadex  G-200  were  pooled  and  concentrated  to  1  ml. 
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Fro.  1.  SP Sephadex chromatography of the QAE Sephadex pool containing properdin. 
The elution positions of properdin (O --O ) detected by radial immunodiffusion (ring diameter 
squared,  D ~) are shown in the upper panel. The capacity of column fractions to react with 
EAC43 and factor B to generate hemolyticaily active sites (Z) in the presence  (O--O) and 
absence  (&--&) of D, is shown in the lower panel. The ionicity (mS) of the salt gradient is 
shown (---). 
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FIG. 2.  Sephadex  G-200 gel filtration of the concentrated SP Sephadex  pool containing 
the second properdin peak (peak II). The elution position of properdin detected by radial 
immunodiffusion  (O--O), and the capacity of fractions to react with EAC43 and factor B to 
generate hemolytically active sites (Z) in the presence  (I--O ) and absence  (A--A) of D 
are shown. The void volume and elution volumes of marker proteins also are indicated. 430  ACTIVATION  OF  FACTOR  D  BY  PROPERDIN 
Two 50-#1 samples, each containing 4/~g properdin, were applied to acid disc 
gels,  and electrophoresis was carried out until the buffer fronts had  traversed 
the  gel  lengths.  One  gel  was  stained  with  Coomassie  blue,  demonstrating  a 
single  band,  and  the paired  gel  was  sliced into  2-ram  segments  which  were 
eluted overnight at 4°C in 0.1  ml of 0.05 M  Tris, pH 8.5, 0.3  M  NaCI.  The 
gel eluates were assessed for their capacity to activate D  by addition of 50 vl 
of 1:5  dilutions in DGVB  ++ of the eluates to 50 ng D  in 50 ~l of DGVB  ++, 
followed by the hemolytic assay for D.  Eluates capable of activating D  were 
obtained from gel slices  corresponding to the single band of protein observed 
in the replicate, stained gel  (Fig. 3). Alkaline disc gel  electrophoresis of 50/zl 
FIO. 3.  Acid disc electrophoresis  of purified properdin. Beneath is shown the amount of 
hemolytically active ~  (Z) generated by interaction of purified D with eluates of each slice 
of the replicate, unstained gel. 
of the properdin preparation revealed no protein bands  and no functional D 
activating activity in gel  eluates, indicating that neither properdin nor other 
contaminating  proteins  entered  the  gel  at  an  alkaline  pH.  Thus,  properdin 
antigenicity and the ability to activate D  corresponded through ion exchange 
and gel filtration chromatography, procedures which had purified properdin to 
homogeneity, as  demonstrated by disc  gel  electrophoresis. The purity of the 
properdin  preparation  was  demonstrated  also  by immunoelectrophoresis  in 
which no precipitin bands were observed with rabbit antinormal human serum, 
while a  single precipitin arc in  the gamma region was developed with mono- 
specific rabbit antihuman properdin. 
To examine further the interaction between properdin and D, the purity of 
the latter was assessed by alkaline disc gel electrophoresis. Samples containing 
5 ~g D, which had been purified by QAE Sephadex and Sephadex G-75 chroma- 
tography and employed in the above experiments, were applied to alkaline disc 
gels.  After electrophoresis, one gel  was stained with Coomassie blue, yielding 
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at 4°C for 2 h in 0.1 ml GVB  ++. To assay for D, 50 ttl of 1:5 dilutions of the 
eluates in DGVB ++ were added to 15 ng properdin in 50 #1 DGVB  ++, followed 
by the hemolytic assay for D. The same eluates were assayed for D  activity in 
the absence of properdin. The protein band in the stained gel corresponded to 
the position in the paired gel  yielding eluates capable of generating D  when 
interacted with properdin (Fig. 4). A small amount of properdin-independent 
D  activity was found in the same region. 
Stoichiometry of the Interaction  Between Factor D and Properdin.--Reaction 
mixtures containing variable amounts of properdin (Fig. 3) and 0.1 #g D  (Fig. 
Fro.  4.  Alkaline disc gel  electrophoresis of purified D. Beneath is shown the amount of 
D hemolytic activity (Z) generated by the interaction of purified properdin (Fig. 3) with 
eluates of each slice of the replicate, unstained gel (O--O). Also shown is properdin-inde- 
pendent 1~ activity present in eluates (@ --@ ). 
4)  in 0.1 ml DGVB ++ were assayed hemolytically for D. A linear relationship 
existed between the input of properdin and the amount of D  generated,  with 
25 ng properdin/108 EAC43 activating sufficient D for production of one hemo- 
lytic site/cell (Fig. 5). Treatment of properdin with 5 X  10  -3 M DFP or 10-  2 M 
TLCK for 60 min at 37°C,  followed by extensive dialysis, resulted in no de- 
crease in the capacity of properdin to activate D. 
For comparison, the capacity of properdin to interact with EAC43 and factor 
B  in the absence of D, noted in Figs.  1 and 2, was examined quantitatively. 
Variable amounts of properdin in 0.1 ml DGVB  ++ were reacted with EAC43 
and factor B, and the hemolytic site developed with C-EDTA. A linear response 
was obtained, with 1/~g properdin/108 EAC43 capable of generating one hemo- 
lytic site/cell (Fig. 5). This amount of properdin is 40 times that giving equiva- 
lent hemolytic activity in the presence of D.  To distinguish this activity of 
properdin  apparent  at  high  concentrations from  that  of 13,  properdin  was 
treated with 5  X  10  -3 M  DFP for  60 min at 37°C,  dialyzed to remove the 
DFP, and hemolytically assayed with EAC43 and factor B. No impairment of 432  ACTIVATION  OF FACTOR  D  BY PROPERDIN 
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Fro.  5.  Hemolytic activity  (Z)  generated  during  incubation  of  EAC43,  factor  B,  and 
variable amounts of properdin, with (O--O) and without  (O --e ) addition of D. The upper 
and  lower scales  represent the amounts of properdin incubated  in the presence and absence 
of D, respectively. 
its activity was seen, although, under the same conditions, the activity of D 
was  greatly  reduced.  To  determine  whether  properdin  acted  by  enhancing 
small amounts of pre-existing i5 that might be present in the D  preparations, 
the effect of properdin on purified [5 was examined. Mixtures containing varia- 
ble amounts of i5, with and without addition of 25 ng properdin/los EAC43, 
were assessed for hemolytic activity; essentially identical results were obtained 
in the presence and absence of properdin. 
To  assess  quantitatively  the  generation  of D  from  limited  D  by  excess 
properdin, variable amounts  of D  were  added  to  15  ng properdin in 0.1  ml 
DGVB  ++,  and  the  mixtures  were  assayed  for  ]~  activity.  The  relationship 
between amount of D  generated and the input of its precursor was linear, and 
175 ng D/10  s EAC43 were sufficient to form one hemolytic site/cell (Fig. 6). 
A reagent blank containing only properdin yielded 0.17 Z, and was subtracted 
from the other reagent mixtures. 
DISCUSSION 
The essential role for i5 in the generation of the C3b-dependent C3 conver- 
tase (5, 8), and the recognition of the precursor form D  (3), indicate the exis- 
tence of a protein in the properdin pathway that is responsible for conversion 
of D  to D. Although C3b is necessary for cleavage of factor B by D, activation 
of D  does not occur with C3b, either in the fluid phase or bound to an erythro- 
cyte (3).  Since purified, activated properdin,  the first factor in  this pathway 
identified  (22)  and isolated  (10),  induces cleavage of factor B  and C3  when DOUGLAS  T.  FEARON,  K.  FRANK  AUSTEN,  AND  SHAUN  RUDDY  433 
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FIo.  6.  Hemolytic  activity  (Z)  generated  during  incubation of  EAC43,  factor  B,  and 
properdin with variable amounts of D. 
added to serum (23), the search  for a protein capable of activating D focused 
on properdin. 
The  hemolytic  assay  for  I5  involving  formation  of EAC43B(I))  (3),  the 
cellular intermediate bearing the C3b-dependent convertase, was used to assess 
quantitatively the ability of chromatographic fractions to activate purified D. 
Radial  immunodiffusion  with  monospecific  antihuman  properdin  antiserum 
was employed to identify fractions containing properdin,  and  allowed  deter- 
mination of the correspondence between properdin protein and the capacity to 
generate ]~ from D  during purification procedures.  Indeed, during sequential 
chromatography  of a  QAE  Sephadex  effluent  on  SP  Sephadex  (Fig.  1)  and 
Sephadex G-200 (Fig. 2), fractions containing properdin antigenically also were 
capable of activating D. Furthermore,  properdin purified in this manner  was 
homogeneous by acid disc gel electrophoretic analysis,  with the band of protein 
staining  corresponding to the position in a replicate gel of eluates capable of 
activating D  (Fig.  3). The purity of D  was demonstrated by alkaline  disc  gel 
electrophoresis in  a  similar  manner  (Fig.  4),  supporting  the contention  that 
direct interaction  between properdin  and D  generates  D.  Assessment  of  the 
hemolytic activity resulting from interaction between properdin and D revealed 
linear  stoichiometric titrations of each factor with properdin effective in nano- 
gram amounts (Figs. 5 and 6). The concordance on ion exchange  and gel filtra- 
tion chromatography between properdin protein and the capacity to activate 
D,  the purity of the preparations used, and the linear  stoichiometry of  their 
hemolytic titrations indicate that direct interaction between properdin  and D 434  ACTIVATION OF  FACTOR  D  BY  PROPERDIN 
results in generation  of D.  In  addition,  the inability of DFP and TLCK  to 
inhibit the capacity of purified properdin  to convert D  to D  excluded activa- 
tion  of D  by potentially  trace-contaminating  proteolytic  enzymes,  such  as 
kallikrein,  plasminogen  activator, and plasma thromboplastin antecedent. 
Properdin alone, in much larger  amounts than required for hemolytic activ- 
ity in the presence of D, was capable of reacting with EAC43 and factor B to 
yield an intermediate susceptible to lysis by C3-C9 (Fig. 5). The insensitivity of 
this  function  to  inactivation  by DFP  excluded the  possibility of action  by 
contaminating  ][5, which  is  DFP-sensitive.  The  finding  that  relatively  large 
amounts of properdin circumvented a need for D is reminiscent  of the observa- 
tions that large amounts of factor B can obviate the requirement for D in  the 
formation  of  the  CoVF-dependent  (24)  and  C3b-dependent  C3  convertases 
(25). 
Other  investigators have obtained properdin  in its  activated state  (23)  as 
indicated by its ability to induce cleavage of C3 and factor B in serum without 
the addition of complex polysaccharides. In this study, using plasma as starting 
material  and  avoiding  chromatography  with  acidic  buffers,  two  forms  of 
properdin were recognized,  distinguishable by their differing effects on D  and 
elution  characteristics  on  SP  Sephadex  chromatography.  Properdin  purified 
from peak II was apparently in its activated state as indicated by its ability 
to generate D from D  and to induce cleavage of C3 when added to serum de- 
pleted of properdin  by prior  adsorption with zymosan  (unpublished results). 
However, properdin  contained  in  peak I  was unable  to  activate D  (Fig.  1) 
and may represent  isolation  of a precursor form  of properdin  which  will be 
useful in the delineation of the early steps in the properdin pathway. That this 
form of properdin is indeed potentially active is revealed by the development 
of D activating activity after repeated freezing and thawing. 
SUMMARY 
The protein in the properdin pathway responsible for conversion  of precursor 
factor D  to D  has  been isolated  and  found  to  be identical  with  properdin. 
Sequential  ion  exchange  and  gel  filtration  chromatography  demonstrated 
identity between properdin protein, measured by radial immunodiffusion,  and 
the capacity to activate D  to ]D, assessed  by formation of the intermediate, 
EAC43B(]~).  Properdin,  purified in  this  manner,  was homogeneous on  acid 
polyacrylamide  disc  gel  electrophoretic  analysis,  with  the  band  of  protein 
corresponding to the position of eluates in the replicate gel capable of activating 
highly purified D. Demonstration of the homogeneity of purified D by alkaline 
disc gel electrophoresis,  coupled with the linear  stoichiometric hemolytic titra- 
tions of each factor, indicates that direct interaction between properdin and D 
generates D. Thus, activation of D by properdin represents a mechanism in the 
properdin pathway by which  ][5 becomes available for formation of the C3b- 
dependent C3 convertase. DOUGLAS T. FEARON, K. FRANK AUSTEN, AND SHAUN RUDDY  435 
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